Cargando…
Intermittent Fasting induced ketogenesis inhibits mouse epithelial ovarian tumors by promoting anti-tumor T cell response
Epithelial Ovarian Cancer (EOC) is the most lethal gynecologic cancer with limited genetic alterations identified that can be therapeutically targeted. In tumor bearing mice, short-term fasting, fasting mimicking diet and calorie restriction enhance the activity of antineoplastic treatment by modula...
Autores principales: | Udumula, Mary Priyanka, Singh, Harshit, Faraz, Rashid, Poisson, Laila, Tiwari, Nivedita, Dimitrova, Irina, Hijaz, Miriana, Gogoi, Radhika, Swenor, Margaret, Munkarah, Adnan, Giri, Shailendra, Rattan, Ramandeep |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10028914/ https://www.ncbi.nlm.nih.gov/pubmed/36945428 http://dx.doi.org/10.1101/2023.03.08.531740 |
Ejemplares similares
-
Intermittent fasting induced ketogenesis inhibits mouse epithelial ovarian cancer by promoting antitumor T cell response
por: Udumula, Mary Priyanka, et al.
Publicado: (2023) -
Divergent Metabolic Effects of Metformin Merge to Enhance Eicosapentaenoic Acid Metabolism and Inhibit Ovarian Cancer In Vivo
por: Udumula, Mary P., et al.
Publicado: (2022) -
A patient perspective on applying intermittent fasting in gynecologic cancer
por: Redding, Ashley, et al.
Publicado: (2023) -
Metformin prevents aggressive ovarian cancer growth driven by high-energy diet: similarity with calorie restriction
por: Al-Wahab, Zaid, et al.
Publicado: (2015) -
Metformin limits the adipocyte tumor-promoting effect on ovarian cancer
por: Tebbe, Calvin, et al.
Publicado: (2014)